Oct 13, 2021
Join UW Vice Provost for Innovation & CoMotion Director François Baneyx as he speaks with Dr. Valerie Daggett, Founder & CEO of UW spinoff AltPep (https://www.altpep.com/) and professor of bioengineering at the University of Washington, about her...
Apr 15, 2021
Bioengineering startup AltPep advances technology for the early detection and treatment of Alzheimer’s and other amyloid diseases.
Jan 15, 2021
Read BioSpace article: Seattle Startup Chases Alzheimer’s with $23 Million Series A
Jan 15, 2021
AltPep announces closing $23.150 million Series A investment round, let by Matrix Capital Management with significant participation by Alexandria Venture Investments. In conjunction with the financing, David Goel, Managing General Partner and Co-founder of Matrix...
Jan 14, 2021
Read Geekwire article: Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases
Sep 20, 2020
Chad is the co-founder and CEO of Adaptive Biotechnologies, a commercial-stage biotech company in Seattle that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease.
Recent Comments